Anuriuswell Pharmaceuticals Priavte Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Ebitda 41.10%
- Net Worth
- Total Assets 36.70%
About Anuriuswell Pharmaceuticals Priavte
Anuriuswell Pharmaceuticals Priavte Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 January 2019 (Six years and one month 7 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mayank Dixit and Ajeet Chauhan serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299PN2019PTC181506
- Company No.
181506
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jan 2019
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Anuriuswell Pharmaceuticals Priavte?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mayank Dixit  | Director | 17-Jan-2019 | Current |
| Ajeet Chauhan | Director | 02-Jan-2020 | Current |
Financial Performance of Anuriuswell Pharmaceuticals Priavte.
Anuriuswell Pharmaceuticals Priavte Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anuriuswell Pharmaceuticals Priavte?
Unlock access to Anuriuswell Pharmaceuticals Priavte's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anuriuswell Pharmaceuticals Priavte?
Unlock and access historical data on people associated with Anuriuswell Pharmaceuticals Priavte, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anuriuswell Pharmaceuticals Priavte, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anuriuswell Pharmaceuticals Priavte's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
